These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 30641790)

  • 21. Lipohypertrophy--a complication of insulin injections.
    de Villiers FP
    S Afr Med J; 2005 Nov; 95(11):858-9. PubMed ID: 16344882
    [No Abstract]   [Full Text] [Related]  

  • 22. Insulin-Induced Skin Lipohypertrophy in Type 2 Diabetes: a Multicenter Regional Survey in Southern Italy.
    Gentile S; Guarino G; Corte TD; Marino G; Fusco A; Corigliano G; Colarusso S; Piscopo M; Improta MR; Corigliano M; MartedÌ E; Oliva D; Russo V; Simonetti R; Satta E; Romano C; Alfarone C; Vetrano A; Martino C; Lamberti C; Vecchiato A; Cozzolino G; Brancario C; Strollo F;
    Diabetes Ther; 2020 Sep; 11(9):2001-2017. PubMed ID: 32683659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Worldwide Injection Technique Questionnaire Study: Population Parameters and Injection Practices.
    Frid AH; Hirsch LJ; Menchior AR; Morel DR; Strauss KW
    Mayo Clin Proc; 2016 Sep; 91(9):1212-23. PubMed ID: 27594185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Turkish Insulin Injection Techniques Study: Complications of Injecting Insulin Among Turkish Patients with Diabetes, Education They Received, and the Role of Health Care Professional as Assessed by Survey Questionnaire.
    Dagdelen S; Deyneli O; Olgun N; Siva ZO; Sargin M; Hatun S; Kulaksizoglu M; Kaya A; Gürlek CA; Hirsch LJ; Strauss KW;
    Diabetes Ther; 2018 Aug; 9(4):1615-1628. PubMed ID: 29961244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of lipohypertrophy in insulin-treated diabetic patients and predisposing factors.
    Hauner H; Stockamp B; Haastert B
    Exp Clin Endocrinol Diabetes; 1996; 104(2):106-10. PubMed ID: 8740933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of lipohypertrophy.
    Kalra S; Kumar A; Gupta Y
    J Pak Med Assoc; 2016 Jul; 66(7):910-1. PubMed ID: 27427150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipohypertrophy in Individuals with Type 2 Diabetes: Prevalence and Risk Factors.
    Sürücü HA; OKur Arslan H
    J Caring Sci; 2018 Jun; 7(2):67-74. PubMed ID: 29977876
    [No Abstract]   [Full Text] [Related]  

  • 28. Lipodystrophy in Insulin-Treated Subjects and Other Injection-Site Skin Reactions: Are We Sure Everything is Clear?
    Gentile S; Strollo F; Ceriello A;
    Diabetes Ther; 2016 Sep; 7(3):401-9. PubMed ID: 27456528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of Lipohypertrophy and its Associations in Insulin-Treated Diabetic Patients.
    Nawaz A; Hasham MA; Shireen M; Iftikhar M
    Pak J Med Sci; 2023; 39(1):209-213. PubMed ID: 36694770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A suitable palpation technique allows to identify skin lipohypertrophic lesions in insulin-treated people with diabetes.
    Gentile S; Guarino G; Giancaterini A; Guida P; Strollo F;
    Springerplus; 2016; 5():563. PubMed ID: 27213130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ultrasound detection of insulin-induced lipohypertrophy in Type 1 and Type 2 diabetes.
    Kapeluto JE; Paty BW; Chang SD; Meneilly GS
    Diabet Med; 2018 Oct; 35(10):1383-1390. PubMed ID: 29908078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Skin-related complications of insulin therapy: epidemiology and emerging management strategies.
    Richardson T; Kerr D
    Am J Clin Dermatol; 2003; 4(10):661-7. PubMed ID: 14507228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Insulin-derived amyloidosis (insulin ball) and skin-related complications of insulin therapy].
    Nagase T; Iwaya K; Zako T; Kikuchi M; Katsura Y
    Nihon Yakurigaku Zasshi; 2023; 158(2):173-177. PubMed ID: 36858501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipohypertrophy and lipoatrophy complicating treatment with highly purified bovine and porcine insulins.
    McNally PG; Jowett NI; Kurinczuk JJ; Peck RW; Hearnshaw JR
    Postgrad Med J; 1988 Nov; 64(757):850-3. PubMed ID: 3076667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipohypertrophy.
    Kalra S; Jawad F
    J Pak Med Assoc; 2016 Jun; 66(6):779-80. PubMed ID: 27339591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New Insulin Delivery Recommendations.
    Frid AH; Kreugel G; Grassi G; Halimi S; Hicks D; Hirsch LJ; Smith MJ; Wellhoener R; Bode BW; Hirsch IB; Kalra S; Ji L; Strauss KW
    Mayo Clin Proc; 2016 Sep; 91(9):1231-55. PubMed ID: 27594187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin antibodies are associated with lipoatrophy but also with lipohypertrophy in children and adolescents with type 1 diabetes.
    Raile K; Noelle V; Landgraf R; Schwarz HP
    Exp Clin Endocrinol Diabetes; 2001; 109(8):393-6. PubMed ID: 11748486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin-Related Lipohypertrophy: Lipogenic Action or Tissue Trauma?
    Barola A; Tiwari P; Bhansali A; Grover S; Dayal D
    Front Endocrinol (Lausanne); 2018; 9():638. PubMed ID: 30425682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An Effective Intervention for Diabetic Lipohypertrophy: Results of a Randomized, Controlled, Prospective Multicenter Study in France.
    Campinos C; Le Floch JP; Petit C; Penfornis A; Winiszewski P; Bordier L; Lepage M; Fermon C; Louis J; Almain C; Morel D; Hirsch L; Strauss KW
    Diabetes Technol Ther; 2017 Nov; 19(11):623-632. PubMed ID: 29058477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence of lipohypertrophy in diabetic patients and a study of influencing factors.
    Vardar B; Kizilci S
    Diabetes Res Clin Pract; 2007 Aug; 77(2):231-6. PubMed ID: 17303282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.